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Abstract
Introduction Measuring the quality of care at the end of life and/or the quality of dying and death can be challenging. Some 
measurement tools seek to assess the quality of care immediately prior to death; others retrospectively assess, following 
death, the quality of end-of-life care. The comparative evaluation of the properties and application of the various instruments 
has been limited.
Objective This systematic review identified and critically appraised the psychometric properties and applicability of tools 
used after death.
Method We conducted a systematic review according to PRISMA (Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses) guidelines by systematically searching MEDLINE, Embase, CINAHL, and PsycINFO for relevant studies. 
We then appraised the psychometric properties and the quality of reporting of the psychometric properties of the identified 
tools using the COSMIN (Consensus-based Standards for the selection of health Measurement Instruments) checklist. The 
protocol of this systematic review has been registered on PROSPERO (CRD42016047296).
Results The search identified 4751 studies. Of these, 33 met the inclusion criteria, reporting on the psychometric properties 
of 67 tools. These tools measured quality of care at the end of life (n = 35), quality of dying and death (n = 22), or both qual-
ity of care at the end of life and dying and death (n = 10). Most tools were completed by family carers (n = 57), with some 
also completed by healthcare professionals (HCPs) (n = 2) or just HCPs (n = 8). No single tool was found to be adequate 
across all the psychometric properties assessed. Two quality of care at the end of life tools—Care of the Dying Evaluation 
and Satisfaction with Care at the End of Life in Dementia—had strong psychometric properties in most respects. Two tools 
assessing quality of dying and death—the Quality of Dying and Death and the newly developed Staff Perception of End of 
Life Experience—had limited to moderate evidence of good psychometric properties. Two tools assessing both quality of 
care and quality of dying and death—the Quality Of Dying in Long-Term Care for cognitively intact populations and Good 
Death Inventory (Korean version)—had the best psychometric properties.
Conclusion Four tools demonstrated some promise, but no single tool was consistent across all psychometric properties 
assessed. All tools identified would benefit from further psychometric testing.
The protocol of this systematic review has been registered on 
PROSPERO, which can be accessed here: http://www.crd.york.
ac.uk/PROSP ERO/displ ay_recor d.php?ID=CRD42 01604 7296 
(Registration number: CRD42016047296).
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4027 1-018-0328-2) contains 
supplementary material, which is available to authorized users.
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Key Points for Decision Makers 
Psychometric information for measures assessing qual-
ity of dying and death and quality of care at the end of 
life was limited, so further research is required before a 
definitive choice of measure can be made.
Based on the limited evidence available, among the 
measures of quality of care at the end of life, the Care of 
the Dying Evaluation and Satisfaction with Care at the 
End of Life in Dementia tools appeared to have the best 
psychometric properties overall.
Among quality of dying and death measures, the Qual-
ity of Dying and Death and Staff Perception of End of 
Life Experience instruments appeared to have the best 
psychometric properties overall.
1 Introduction
By 2040, of people dying in England and Wales, 87.6% will 
need palliative care [1]. People at the end of life may experi-
ence difficult symptoms, such as pain, difficulty breathing, 
and confusion [2]. Multiple tools seek to assess the quality 
of care at the end of life and the quality of dying and death 
[3–7]. However, assessing the quality of dying and death and 
of end-of-life care can be challenging because of declining 
health towards the end of life, the difficulty of identifying 
people who may be in the dying phase, and the sensitivity 
of involving family members in quality assessment at this 
time. Additionally, development and validation of new tools 
is costly and time consuming. Thus, research might more 
productively evaluate and improve existing tools rather than 
developing new ones.
Tools that assess quality of care at the end of life reflect 
the provision of care and include items that assess the envi-
ronment, communication with health and social care prac-
titioners, and nursing care. In contrast, tools designed to 
assess quality of dying and death include items that reflect 
physical, psychological, emotional, and spiritual needs; 
symptom burden; and place of death. Several published 
systematic reviews have assessed the utility of these tools in 
various clinical populations, including dementia and cancer 
[3–7]. Notably, a recent review distinguished between tools 
assessing quality of dying and death and those examining 
quality of care in long-term care settings [7]. Similarly, 
van Soest-Poortvliet et al. [6] used a structured approach 
to assess the psychometric properties of tools developed 
to capture the quality of end-of-life care and of dying in 
long-term care settings and how they may differ for people 
with and without dementia. However, this group based their 
assessment of the psychometric properties of tools in this 
field on data they collected in the USA and the Netherlands. 
The present review is broader. It assesses the psychometric 
properties of all tools developed and validated to evaluate, 
following death, the quality of dying and death and of care 
at the end of life across multiple settings and the methodo-
logical quality of the studies reporting these psychometric 
properties. Although retrospective recall of these concepts 
is susceptible to issues relating to recall bias, this approach 
overcomes the issue of whether or not the patient was at the 
end of life.
This review uses the COSMIN (consensus-based stand-
ards for the selection of health measurement instruments) 
[8], a taxonomy developed to standardise terminology and 
definitions of psychometric properties [9] and provide guid-
ance on the best methods for developing and validating tools 
[10]. Since its development, the COSMIN [8] has been used 
to assess tools developed for various clinical populations, 
including dementia [11, 12] and breast cancer [13], and tools 
assessing quality of life in palliative care samples [14] and 
quality of care and dying in long-term care settings [6].
1.1  Aims
This systematic review aimed to (1) identify all tools that, 
after death, assess the quality of death and dying and of care 
at the end of life, (2) evaluate the psychometric properties 
of these tools, and (3) recommend validated tools for use in 
research and clinical practice.
2  Method
The protocol for this review is registered on PROSPERO 
(CRD42016047296) and follows the PRISMA (Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses) 
guidelines [15]. See the Electronic Supplementary Material 
(ESM) 1 for the PRISMA checklist.
2.1  Search Strategy
We searched the Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Embase, MEDLINE, and 
PsycINFO databases from inception to 15 May 2017 using 
search terms including medical subject heading (MeSH) 
terms for tools, end of life, quality of death and dying, and 
quality of care (Box 1). Terms for the end-of-life care popu-
lation were extracted from a previous Cochrane review [16]. 
The reference lists of included studies and relevant reviews 
were examined to identify additional suitable studies.
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2.2  Eligibility Criteria
Inclusion criteria were as follows: (1) studies assessed at 
least one psychometric property of a tool assessing quality 
of death and dying and/or of care at the end of life of adult 
palliative care patients in either inpatient or community set-
tings, (2) tools were completed after death by family and 
healthcare professionals (HCPs) of deceased patients, (3) 
studies were reported in English even if psychometric prop-
erties of the tool were developed and validated in another 
language, and (4) studies were published in peer-reviewed 
journals. Exclusion criteria were studies that reported (1) 
ad hoc tools, (2) single-item tools, (3) tools developed for 
study purposes, and (4) tools developed for critical care 
settings (e.g., intensive care units). As the COSMIN was 
developed to assess the methodological quality of studies 
using classical test theory or item response theory (IRT), we 
excluded studies that used other methods such as generalis-
ability theory [17]. Studies of assessment tools such as the 
Mini-Suffering State Examination (MSSE) [18] and Pallia-
tive Outcome Scale (POS) [19] were excluded because the 
MSSE assesses a variety of symptoms that are not designed 
to correlate and thus are not reflective of an overall con-
struct. The POS has been shown to capture two factors and 
some independent items that do not load onto these factors 
[20], making this measure less ideal for the assessment of 
internal consistency and factor structure.
2.3  Study Selection
The study selection process consisted of two phases. First, 
review of all citations followed by a full-text review of stud-
ies that fitted the inclusion criteria according to this ini-
tial screening process. One researcher (NK) screened all 
titles and abstracts, and three reviewers (BV, JH, TA) each 
independently assessed a random sample of 250 abstracts 
and titles (750 in total). Any discrepancies were resolved 
through discussion and consensus. This process aimed to 
Box 1: Search terms used
#1 (Tool or Assess* or Survey or Queson* or Measur* or Method or Scale or Checklist or 
Rang or Test or Instru* or Inventory or Technique or Monitor or Observ* or Rate or  Funcon 
or scoring system or Outcome*)
#2 (palliat* or terminal* or endstage or hospice* or (end adj3 life) or (care adj3 dying) or 
((advanced or late or last or end or final) adj3 (stage* or phase*)))
#3 (Quality of death or Quality of dying or Sas* with care or Good death or Bad death or 
Comfort)
#4 1 and 2 and 3
facilitate clarity and agreement in the study group that our 
inclusion criteria was appropriate and sufficiently detailed 
to apply. One researcher (NK) screened all full-text studies 
and consulted with a second reviewer (TA) if the relevance 
of a study was unclear. Study authors were contacted if the 
relevance of a paper was unclear or additional information 
was required.
2.4  Data Extraction
Two reviewers (NK in all cases, plus one of TA, GTR, 
GS, NW, SH, and TF) independently extracted data from 
each study using a standardised data extraction form. Data 
extracted were country of origin, aim of study, tool(s) 
developed and/or validated, tool aim(s), number of items, 
response scale, language of tool assessed, respondent (infor-
mal [family] or paid [HCP] carer), recall period, method 
of administration, study setting, patient population, sample 
size, and sample demographic information of respondents 
and/or of the deceased patients.
2.5  Assessment of Psychometric Properties
Psychometric properties of tools were appraised using estab-
lished quality criteria ([21, 22]; Table 1). The COSMIN 
provides guidance for assessing a range of psychometric 
properties, including validity (content, construct [structural, 
hypothesis testing, and cross-cultural], and criterion), reli-
ability (internal consistency, reproducibility [agreement and 
reliability over time and between and within raters], respon-
siveness and floor and ceiling effects). To our knowledge, 
there is no ‘gold standard’ tool for measuring the quality of 
care at the end of life and quality of dying, and thus criterion 
validity was not assessed. Each psychometric property was 
scored using a four-point rating scale: positive (+), indeter-
minate (?), negative (−), or no information (0). The criteria 
for the positive, indeterminate, and negative ratings for each 
of the psychometric properties assessed in this review are 
presented in Table 1.
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2.6  Assessment of Methodological Quality
We used the COSMIN checklist to appraise the methodo-
logical quality of studies reporting on psychometric proper-
ties of the tools [21]. This checklist comprises nine boxes, 
each rating a specific psychometric property. Each psycho-
metric property is rated on 5–18 items as excellent, good, 
fair, or poor. Methodological and psychometric quality 
were assessed for all psychometric properties except cross-
cultural validity and IRT, which were only rated on meth-
odological quality. Appraisal of each measure was based 
on the overall tool where possible; however, for studies that 
reported the psychometric properties of individual subscales 
rather than the overall tool, these scales were assessed indi-
vidually. Assessment of psychometric property and meth-
odological quality for each study was completed by two 
independent reviewers (NK for all studies, plus one of TA, 
GTR, GS, NW, SH, and TF). Each rating was compared 
and any discrepancies between the two reviewers discussed 
and resolved, with a third rater consulted if no resolution 
could be reached. Intraclass correlation coefficients (ICCs) 
between reviewers for the assessment of methodological 
quality of each psychometric property ranged between 0.70 
and 0.97, and high agreement was found for psychometric 
property appraisal (ICC range 0.87–1.0).
2.7  Levels of Evidence
The psychometric property assessed for each measure was 
accompanied by an assessment of the level of evidence 
available to support the rating. The level of evidence was 
determined by the number of studies reporting on the psy-
chometric property of the measure, the methodological 
quality as assessed by the COSMIN, and the agreement 
between studies if more than one had been conducted. Each 
psychometric property was rated either as strong (consist-
ent findings across several studies with a methodological 
rating of ‘good’ or one study rated as ‘excellent’), moderate 
Table 1  Quality criteria used to assess psychometric properties of measures [22]
Psychometric property ratings: + indicates positive; ? indicates indeterminate; − indicates negative
ICC Intraclass correlation coefficient, IRT item response theory
Psychometric property Definition Rating Quality criteria
Internal consistency The extent to which the items correlate, indicating that 
the overall tool is measuring the same construct
+ Data from adequate sample used to conduct factor 
analysis and Cronbach’s α per factor between 0.70 
and 0.95
? No factor analysis conducted
− Cronbach’s α < 0.70 or > 0.95
Reliability The degree to which the scores are free from measure-
ment error
+ ICC or weighted kappa ≥ 0.70
? ICC or weighted kappa not reported or inappropriate 
statistical method reported
− ICC or weighted kappa < 0.70
Content validity The extent to which the items reflect the construct 
being assessed
+ Detailed description of tool development, including 
tool aim, target population, concepts under assess-
ment, item selection, and the population (patient and 
experts) involved in item selection
? Aspects of tool development lack description or only 
target population involved
− No target population involved
Structural validity The degree to which the scores of the tool adequately 
reflect the dimensions of the construct being 
assessed
+ Factor analysis demonstrates that combined set of fac-
tors explain ≥ 50% of total variance in the model OR 
IRT methods confirm (uni) dimensionality
? Proportion of variance explained not reported
− <50% of the total variance explained by model
Hypothesis testing The extent to which the scores of the tool are consist-
ent with pre-formulated hypotheses
+ Specific hypotheses were formulated and at least 75% 
of the results in line with hypotheses
? No a priori formulated hypotheses
− Results confirm < 75% of hypotheses
Cross-cultural validity The degree to which the items on a translated version 
are an adequate reflection of the original version
Assessed using methodological quality criteria only
Item response theory Assesses whether responses on a set of items are 
related to an unmeasured ‘trait’
Assessed using methodological quality criteria only
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(consistent evidence across several studies rated as ‘fair’ or 
one study rated as ‘good’ in methodological quality), limited 
(findings from one study rated as ‘fair’), unknown (findings 
from studies rated as ‘poor’ available), or conflicting (incon-
sistent findings across different studies) [23].
2.8  Data Synthesis
Rating data from different studies evaluating the same tools 
were grouped based on the methodology. Data from stud-
ies that used the same version of the tool (i.e. on the same 
items, response scale, and language) and collected data from 
the same types of respondents (i.e. family carers or HCPs) 
were suitable for grouping. For tools where it was not pos-
sible to group the data from two or more studies, the ratings 
for each study were presented individually. For tools where 
data grouping was possible, only data for the psychometric 
properties rated as fair, good, or excellent on methodological 
quality as assessed by the COSMIN [21] were used.
We used the COSMIN [21] to assess the psychometric 
properties of each tool and the methodological quality of 
reporting, but, to make a global comparison between the tools, 
we developed an additional ad hoc scoring system, assign-
ing a score for the psychometric property rating and level of 
evidence for each psychometric property assessed (Box 2).
Box 2: Scoring system used to compare overall properes of the tools
Psychometric property rang Level of evidence Score assigned
+ Strong +3
+ Moderate +2
+ Limited +1
- Limited -1
- Moderate -2
- Strong -3
Psychometric properties that were rated as indetermi-
nate (?), unknown, or conflicting were assigned a score of 
0. The scores assigned for each psychometric property were 
summed to give an overall score for each tool.
3  Results
3.1  Search Results and Study Selection
A total of 4751 studies were retrieved from the database 
searches. Following screening of abstracts and titles, 347 
studies were taken forward for full-text review, and 28 stud-
ies fitted the inclusion criteria. Reference list checks of the 
28 relevant studies identified an additional five relevant 
studies, resulting in a final list of 33 studies to be included 
in the review. A PRISMA flow diagram of the screening 
process is presented in Fig. 1.
In total, the 33 studies assessed 67 tools. The majority 
of the studies assessed the psychometric properties of tools 
completed by family carers (n = 57), but some were com-
pleted by HCPs (n = 8) or both (n = 2). The tools were com-
pleted in English (n = 44), Dutch (n = 11), German (n = 2), 
Japanese (n = 4), Korean (n = 2), Spanish (n = 2), and Italian 
(n = 1). Another study used both English and Spanish ver-
sions of a tool. Studies were conducted in the USA (n = 14), 
Japan (n = 4), UK (n = 3), Netherlands (n = 3), Korea (n = 2), 
and Germany (n = 2). One study was international, with par-
ticipants from Canada, Chile, Ireland, Italy, and Norway. 
Studies evaluated the quality of care and of dying and death 
in palliative care units (n = 10); long-term care settings, 
including nursing homes (n = 7), hospitals (n = 2), hospices 
(n = 1), home (n = 1), outpatient units (n = 1); and across 
various settings (n = 9). The clinical populations were from 
a mixed sample (n = 15) or had advanced cancer (n = 14) or 
advanced dementia (n = 4).
All but one study [7] evaluated the psychometric proper-
ties of the overall tool and/or the subscales of the tool except 
for the minimum data set (MDS), which was evaluated as 
individual subscales rather than an overall tool. ESM 2 pro-
vides a summary of the included studies. Tools completed 
by family carers and HCPs, translated versions, and tools 
evaluated as independent subscales were evaluated individu-
ally, providing assessments of 67 tools. Of these tools, 35 
assessed quality of care, 22 measured quality of dying and 
death, and ten assessed both. While the majority of stud-
ies assessed the psychometric properties of one version 
of a measure completed by a single sample (n = 21), some 
assessed two (n = 8), three (n = 1), four (n = 1), 11 (n = 1), or 
12 (n = 1) individual tools that differed either in what they 
evaluated or in the respondent who completed the measure 
(family carer or HCPs). ESM 3 provides a summary of all 
tools used in each included study.
3.2  Psychometric Properties of Tools
Data on psychometric properties for all of the tools could 
not be grouped because of substantial differences between 
studies in the versions of the tools used (i.e. original, abbre-
viated, different language), the method of using the tools 
(i.e. family carers and/or HCPs, self-administered and/or 
interview), and the settings (i.e. long-term care, hospice, 
hospital). Therefore, rating data on tools from two or more 
studies that could not be grouped are presented individually, 
whereas studies that used the same tools with similar meth-
odology have been grouped. Table 2 provides a summary of 
the rating assigned for each psychometric property, the level 
of evidence, and the overall score for each tool, and ESM 
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Fig. 1  PRISMA (Preferred 
Reporting Items for Systematic 
Reviews and Meta-Analyses) 
flow diagram of study selection. 
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4 provides the appraisal of the psychometric properties of 
tools and the methodological quality of studies using the 
COSMIN checklist.
3.2.1  Psychometric Properties of Tools Assessing Quality 
of Care at the End of Life
The tools identified to assess quality of care at the end of 
life are shown in Table 2. From these tools, it was pos-
sible to group the data from two studies assessing the 
SWC-EOLD (Satisfaction With Care at the End of Life 
in Dementia) [7, 24], FPCS (Family Perceptions of Care 
Scale) [7, 25], TIME (Toolkit of Instruments to Meas-
ure End of life care after-death bereaved family member 
interview) [7, 26], and ECHO-D (Evaluating Care and 
Health Outcomes-for the Dying) [27, 28]. Internal con-
sistency, structural validity, and hypothesis testing were 
assessed for all four tools, whereas content validity was 
evaluated for SWC-EOLD [7, 24] and FPCS [7, 25], and 
reliability was assessed for TIME [7, 26] and the ECHO-D 
[27, 28]. The SWC-EOLD [7, 24] had strong evidence of 
positive internal consistency, with Cronbach’s alpha (α) 
ranging between 0.83 and 0.90, but a moderate to strong 
level of evidence of an indeterminate rating for structural 
validity and hypothesis testing and an indeterminate rat-
ing from one study of poor methodological quality (thus 
rated as unknown) for content validity. In contrast, limited 
evidence showed that the FPCS [7, 25] had a negative 
rating for internal consistency (α = 0.95 and 0.96) but a 
positive rating for content and structural validity and an 
indeterminate rating for hypotheses testing. The TIME [7, 
26] measure had moderate evidence for positive internal 
consistency (α = 0.94) but was indeterminate for structural 
validity and hypothesis testing and unknown for reliability. 
The ECHO-D [27, 28] also had limited evidence of posi-
tive internal consistency (α = 0.78–0.93) for the subscales 
and was suitable for hypothesis testing but scored nega-
tively for test–retest reliability (kappa [κ] < 0.70).
For tools where data grouping was not possible, the FATE 
(Family Assessment of Treatment at the End of life)-32 [29], 
FAMCARE (Family satisfaction with end-of-life Care)-5 
and -10 [30], CODE (Caring Of the Dying Evaluation) [31], 
FPPFC (Family Perceptions of Physician-Family Caregiver 
Communication) [7], and MDS-Mood [7] were all assigned 
a positive rating for internal consistency (α = 0.74–0.94) but 
with varying levels of evidence. For reliability, the Japanese 
versions of the CES (Care Evaluation Scale) and CES-10 
[32] had moderate levels of evidence for positive test–retest 
reliability (ICC = 0.82–0.83). FATE-32 [29], CQ-Index-PC 
(Consumer Quality Index Palliative Care) [33], QPM-SF 
(Post Mortem Questionnaire-Short Form) [34], SAT-Fam-
IPC (Satisfaction Scale for Family members receiving Inpa-
tient Palliative Care) [35], CES [36], and CODE [31] all had wi
th
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strong to moderate levels of evidence of positive content 
validity, with strong evidence for QPM-SF [34] and CODE 
[31]. QPM-SF [34], FAMCARE [37], FAMCARE-5 and 
FAMCARE-10 [30], and SAT-Fam-IPC [35] all had positive 
structural validity properties, with a strong level of evidence 
for FAMCARE [37]. Cross-cultural validity was assessed for 
FATE-S-14 [38]; Dutch versions of the FATE-S-12, FPCS, 
TIME, and FPPFC [39]; SAT-Fam-IPC [35]; and the Korean 
and English versions of the CES [36, 40]. However, all stud-
ies were rated as poor for methodological quality except for 
the Korean version of the CES [40], which was rated as fair. 
Thus, the cross-cultural validity for the majority of tools is 
unknown (or limited in the case of the Korean version of 
the CES [40]). Although the CES [40] was rated as good to 
excellent on the majority of the methodological quality cri-
teria, the authors failed to describe the expertise of the trans-
lators with respect to disease, construct, and language, and 
whether the translators worked independently was unclear. 
IRT methodology was used to assess the three versions of 
the FAMCARE scales (FAMCARE [37], FAMCARE-10 
and FAMCARE-5 [30]); based on methodology, these were 
rated as good with moderate levels of evidence.
Using our ad hoc scoring system to assign an overall 
score for each tool, 15 of the 30 tools were assigned a 
positive score, with the CODE [31] and SWC-EOLD [7, 
24] assigned a score ≥ + 3, whereas the MDS-Social [7], 
MDS-Symptoms [7], the Korean version of the CES [40], 
and the CEQUEL (Caregiver Evaluation of the Quality of 
End of Life care) [41] scored poorly (− 1 to − 3).
3.2.2  Psychometric Properties of Tools Assessing Quality 
of Dying and Death
The tools assessing quality of dying and death are shown in 
Table 2. Of these tools, it was possible to group data from 
studies with family carers assessing the CAD-EOLD (Com-
fort Assessment in Dying at the End of Life in Dementia), 
the SM-EOLD (Symptom Management at the End of Life 
in Dementia) [7, 24], and the QODD (Quality of Dying and 
Death) [42, 43]. Assessment outcomes of internal consist-
ency for these tools were either conflicting (CAD-EOLD and 
SM-EOLD [7, 24]) or unknown (QODD [42, 43]). Although 
Cronbach’s α for CAD-EOLD was within an acceptable 
range (α = 0.74–0.85), one study [24] did not employ an ade-
quate sample (< 100). The internal consistency evaluation of 
the SM-EOLD in two studies also differed, with one report-
ing a Cronbach’s α of 0.72 [7]; although the overall scale 
internal consistency reported from the second study was 
within an acceptable range (α = 0.78), the subscales were 
found to have Cronbach’s α of 0.47–0.81 [24]. One study 
assessed the internal consistency for the QODD, but this was 
rated as unknown because the factor structure was not evalu-
ated [42]. Content validity was assessed for CAD-EOLD and 
SM-EOLD for family carers [24] but was rated unknown 
because of the poor level of evidence. The QODD had a 
strong level of evidence for structural validity from two sam-
ples employed by one study [43], but this study failed to 
report the proportion of variance explained by the factorial 
models and thus was rated as indeterminate. The data for 
structural validity of the CAD-EOLD and SM-EOLD [7, 24] 
were conflicting. The assessment of hypothesis testing of the 
CAD-EOLD and SM-EOLD [7, 24] were both indeterminate 
because hypotheses were lacking. QODD was found to have 
positive hypothesis-testing properties, as one study formu-
lated and presented specific hypotheses and at least 75% of 
the results were in line with the hypotheses [42].
For tools where data could not be grouped, the major-
ity were rated as unknown or indeterminate on psychomet-
ric assessment. The Dutch version of the CAD-EOLD for 
HCPs [39] had negative internal consistency (α for subscales 
ranged between 0.64 and 0.89). Similarly, the German ver-
sions of the QODD for family carers and HCPs (QODD-
D-Ang [QODD-Deutsch-Angehörige] [44] and the QODD-
D-MA [QODD-Deutsch-Mitarbeiter] [45], respectively) 
both had negative structural validity because factor analysis 
demonstrated that all the factors together explained < 50% 
of the total variance (QODD-D-Ang = 44.97%; QODD-D-
MA = 43.8%). Cross-cultural validity was assessed for the 
QODD-D-Ang [44], QODD-ESP (Spanish version) [46], 
and QODD-D-MA [45]. Although both the QODD-D-Ang 
[44] and QODD-D-MA [45] were rated as excellent for the 
majority of criteria, neither study performed a confirmatory 
factor analysis. A confirmatory factor analysis is required 
to test for differences between the original and translated 
versions of the tool and to identify whether any items do 
not load on the original factor structure, suggesting that the 
items have a different meaning in the translated version. In 
contrast, a confirmatory factor analysis was conducted to test 
the factor structure of the QODD-ESP [46], but this tool was 
rated as limited because it scored as fair on several criteria. 
The authors failed to describe the expertise of the transla-
tors with respect to disease, construct, and language, it was 
unclear whether the translators worked independently, and 
only one forward and one backward translation of the items 
was conducted.
Using our ad hoc scoring system, of the 15 tools, only 
the SPELE (Staff Perception of End of Life Experience) for 
HCPs [47] and the QODD for family carers [42, 43] had a 
positive score but with a moderate to limited level of evi-
dence. In contrast, the Dutch version of the CAD-EOLD for 
HCPs [39], the QODD-D-Ang for family carers [44], and the 
QODD-D-MA for HCPs [45] were rated negatively.
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3.2.3  Psychometric Properties of Tools Assessing Both 
Quality of Care at the End of Life and Quality of Dying 
and Death
The tools identified to assess both quality of care at the end 
of life and quality of dying and death are shown in Table 2. 
We found substantial differences between studies assessing 
the same tools, so it was not possible to group the data for 
these tools. Internal consistency was positive for the QOD-
LTC-C (Quality Of Dying in Long-Term Care of Cogni-
tively intact decedents) [48] as completed by both family 
carers and HCPs and the Korean version of the GDI (Good 
Death Inventory) for family carers [49] (α = 0.85 and 0.93, 
respectively). However, internal consistency was negative 
for QOD-LTC (Quality Of Dying in Long-Term Care) as 
completed by family carers and HCPs [48] and the Dutch 
version for HCPs [39]. Cronbach’s α for the subscales ranged 
from 0.49 to 0.66 and from 0.37 to 0.75, respectively. Inter-
rater reliability was negative for the QOD-Hospice (Quality 
Of Dying-Hospice scale) [50] and the QOD-LTC for family 
carers and HCPs [48], and the Japanese version of the GDI 
for family carers [51] had negative test–retest reliability. 
The authors reported ICC values of 0.49, 0.35, and 0.52, 
respectively. Where an assessment of structural validity was 
available, the tools were rated as unknown or indeterminate, 
except for the QOD-LTC for both family carers and HCPs 
[48], which was rated negative. The factor analysis found 
that the model explained 49% of the total variance. Although 
the authors formulated and reported specific hypotheses for 
the QOD-Hospice, the hypotheses testing for this tool was 
rated as negative because the results were not in line with 
at least 75% of the hypotheses [50]. Cross-cultural validity 
was assessed for Dutch versions of the QOD-LTC for family 
carers and HCPs [39] (rated as unknown) and the Korean 
version of the GDI [49] (rated as limited). The GDI [49] 
was rated as limited because, similar to other tools assessed 
in this study, the authors failed to report the expertise of the 
translators and did not clearly describe whether the transla-
tors worked independently.
Using our ad hoc scoring system, two of the ten tools 
(QOD-LTC-C for family carers and HCPs [48] and the 
Korean version of the GDI for family carers [49]) were rated 
positively and had a strong level of evidence. In contrast, 
four tools (the Dutch version of the QOD-LTC for HCPs 
[39], QOD-Hospice for family carers [50], the Japanese ver-
sion of the GDI for family carers [51], and the QOD-LTC 
for family carers and HCPs [48]) were rated negatively, with 
the QOD-LTC for family carers and HCPs [48] assigned a 
score of − 8.
4  Discussion
4.1  Findings
To our knowledge, this is the first systematic review to iden-
tify and appraise psychometric properties while considering 
the associated levels of evidence for tools that, after death, 
assess the quality of care at the end of life and the quality 
of dying and death. Our review identified 33 studies that 
reported on versions of 35 tools assessing quality of care 
at the end of life, 22 tools assessing quality of dying and 
death, and ten assessing both constructs. Data on psycho-
metric properties could not be grouped for every measure 
because of the variability between studies in the versions of 
tools used (i.e. original, abbreviated, different language), the 
method of using the tools (i.e. family carers and/or HCPs, 
self-administered and/or interview), and the settings (i.e. 
long-term care, hospice, hospital). However, no measure 
was adequate across all psychometric properties.
Our ad hoc scoring system rated half of the tools 
designed to assess quality of care positively. In particular, 
the CODE [31] which, although not psychometrically eval-
uated since it was developed, was initially assessed on five 
psychometric properties, with overall strong evidence of 
positive measurement properties. The CODE is a 30-item 
self-report measure developed from the ECHO-D [27, 28]. 
This tool is designed to assess the environment of the care 
setting, communication with HCPs, and the care provided 
to the patient in the last days of life. Despite its limited 
use, the CODE has some promising psychometric proper-
ties and thus should be developed and validated further. 
Another tool that also demonstrated strong evidence of 
positive psychometric properties, including internal con-
sistency, is the SWC-EOLD [7, 24]. This tool is predomi-
nately used in long-term care settings to evaluate carers’ 
satisfaction with end-of-life care provided to people living 
with dementia in the last 90 days of life. This is a 10-item 
self-report tool designed to assess decision making, com-
munication with HCPs, understanding of dementia, and 
level of nursing care. Despite its extensive use in research, 
the SWC-EOLC would benefit from further psychometric 
evaluation, particularly, structural validity and hypotheses 
testing.
In contrast, the Korean version of the CES [40] and 
the CEQUEL [41] had strong evidence for negative and 
indeterminate ratings, suggesting that, to date, these tools 
have poor psychometric properties and thus require fur-
ther development and validation. The majority of the 
psychometric properties of the tools developed to assess 
the quality of dying and death were rated as unknown or 
that the available evidence was conflicting, thus mak-
ing it challenging to arrive at a firm conclusion on their 
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psychometric properties. For example, the majority 
of studies that assessed cross-cultural validity failed to 
adequately describe the translators with respect to their 
expertise on dying, death, and satisfaction with care, and 
the language, and whether the translators worked indepen-
dently while translating the items was unclear.
On a positive note, the newly developed SPELE [47], 
which has been assessed for structural validity and con-
tent validity, had a moderate level of evidence of positive 
psychometric properties. The SPELE is a comprehensive 
63-item tool designed to assess HCP’s experiences of 
various aspects of quality of dying and death, including 
the environment, symptoms, decision making, and com-
munication in the last week of life. This promising tool, 
although yet to be developed further, can be used across a 
variety of healthcare settings. In comparison, the QODD 
[42, 43], which was adapted from the original version and 
has been extensively used, also has some positive psycho-
metric qualities. This 31-item tool measures a number of 
factors, including preparation for death, moment of death, 
and treatment preferences. As demonstrated by this review, 
the QODD has been translated into German and Span-
ish and used by both family carers and HCPs. However, 
despite extensive use, it still requires further validation, 
particularly for internal consistency and reliability.
Finally, of the ten tools designed to assess the quality of 
care and of dying and death, only the QOD-LTC for cog-
nitively intact samples [48] and the Korean version of the 
GDI [49] had positive psychometric properties. Overall, 
the findings demonstrate that, of the numerous tools avail-
able to assess the quality of care and of dying and death, 
none have undergone a full psychometric evaluation with 
all psychometric properties evaluated. Further psychomet-
ric evaluation of the tools identified and assessed in the 
present review is required.
4.2  Strengths and Limitations
This systematic review can be considered of high methodo-
logical quality according to the quality criteria for systematic 
reviews proposed by Terwee et al. [52]. It used a compre-
hensive but broad search strategy without date restrictions 
to seek to capture all relevant articles from several key 
large citation databases and reference lists of suitable stud-
ies. Search terms for measurement properties were not 
used because of the great variation in the terminology, as 
recommended by the developers of the COSMIN [52]. A 
proportion of relevant studies were only identified through 
reference list checks, because the broad search strategy used 
when searching electronic databases still required studies 
to be correctly indexed and for appropriate keywords to be 
included in the title/abstract, but this was not always the 
case. A single reviewer (NK) assessed all of the results of 
the search, but three secondary reviewers independently 
assessed a random sample of 750 titles and abstracts, and 
any discrepancies were resolved by discussion.
Only studies that aimed to develop and/or validate tools 
assessing, following death, the quality of care at the end of 
life and of dying and death were included in this review, 
so studies that assessed psychometric properties of tools as 
a secondary aim (i.e. it is common for research studies to 
include Cronbach’s α of tools as an assessment of internal 
consistency) were excluded. Additionally, we included stud-
ies that reported psychometric properties of tools developed 
or validated in other languages to identify cross-cultural 
psychometric evidence for the tools of interest. Thus, this 
review is not restricted to English language tools or English-
speaking populations and cultures.
The use of a well-defined and structured quality assess-
ment such as the COSMIN provides a rigorous approach to 
psychometric evaluation. However, the COSMIN is not suit-
able for assessing studies that have used other methods, such 
as generalisability theory, as it was developed to assess the 
methodological quality of studies using classical test theory 
or IRT. In addition, some of the items used by the COS-
MIN can be subjective, thus, each study was assessed and 
rated independently by two reviewers to overcome this issue. 
Again, one reviewer (NK) assessed all studies and trained all 
assessors prior to data extraction and psychometric assess-
ment to ensure consistency in assessment. All assessments 
were discussed between the two initial reviewers, and a third 
was involved if agreement could not be reached.
To compare tools based on an overall psychometric evalu-
ation, the research team developed an ad hoc scoring system. 
However, this should be regarded as a qualitative rather than 
quantitative evaluation of the psychometric properties of the 
scales and allows readers to make broad evaluations about 
the scales. However, specific scales may have particular mer-
its or drawbacks not revealed by the global score, so readers 
should look at the evidence for those scales and draw their 
own conclusions about which scale may be best for their 
study or clinical practice.
Finally, this review focused on studies that assessed the 
quality of care and of dying and death retrospectively. There-
fore, the psychometric evaluations of the tools identified in 
this review are based on proxy ratings by family carers and 
HCPs of how they perceived these experiences following 
death. Thus, this review is limited to the psychometric evalu-
ation of tools completed after a death and is not applicable 
to the psychometric properties of these tools assessed before 
death has occurred.
4.3  Implications
The availability of well-developed and validated tools for 
quality of care at the end of life and quality of dying and 
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death are important for several reasons. First, if ‘gold stand-
ard’ tools of these constructs existed, comparisons across 
studies and cultures would enable a better understanding 
of the similarities and differences between settings. Sec-
ond, a global measure would eliminate the use of diverse 
benchmarks for classifying what represents a ‘good’ or 
‘bad’ death, for example, it has been previously suggested 
that dying in the place of preference suggests the person 
experienced a ‘good’ death [53], but this may not always 
be the case. Additionally, some of the tools identified in 
this review are designed for specific populations such as 
dementia [24] and thus may not be transferable across clini-
cal populations. Finally, tools are essential for evaluating 
interventions designed to improve quality of care and quality 
of dying and death. Poorly designed and validated tools may 
compromise how results of an intervention are interpreted. 
Therefore, reviews of this kind are important and highlight 
that, although many tools of these constructs are available, 
more work remains to be done on validating and improv-
ing the psychometric properties of these tools. Conducting 
research with palliative care populations, whether before or 
after death, can be uniquely challenging. Researchers and 
clinicians can use the information provided by this review as 
a whole or as provided for each measure to make appropriate 
decisions for which measure would be best suited for their 
purpose and how similar tools may compare.
5  Conclusion
This systematic review has identified and critically appraised 
tools for assessing, following death, the quality of care at 
the end of life and of dying and death. This evaluation has 
demonstrated that a limited number of tools exists and that 
they show some promising psychometric properties but still 
need further investigation. Despite the abundance of tools 
available to assess the quality of dying and death and satis-
faction with care at the end of life, many gaps remain in our 
understanding of the psychometric properties of these tools. 
Future research, rather than seeking to develop new tools, 
might more productively focus on improving and validating 
existing tools.
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